- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07942675
Indirect Calorimetry-Guided Nutritional Support in Mechanically Ventilated Children (CALI-PED) (CALI-PED)
Use of Indirect Calorimetry to Guide Caloric Intake in Children on Mechanical Ventilation in the Pediatric Intensive Care Unit: A Prospective Comparative Study
Adequate nutritional support is essential in critically ill children receiving invasive mechanical ventilation. Current nutritional prescriptions are commonly based on predictive equations, which may inaccurately estimate individual energy requirements and contribute to underfeeding or overfeeding.
CALI-PED is a single-center, prospective, interventional pilot study designed to evaluate whether indirect calorimetry-guided nutritional support reduces interindividual variability in energy intake adequacy among mechanically ventilated children in the pediatric intensive care unit (PICU).
Fifty children will be prospectively enrolled and compared with a historical cohort of 141 patients managed using conventional nutritional targets based on the Schofield predictive equation. In the prospective cohort, resting energy expenditure will be measured daily using indirect calorimetry, for up to seven days of invasive mechanical ventilation, and enteral caloric prescriptions will be adjusted accordingly.
The primary outcome is the interindividual variability in the ratio of actual energy intake to the reference energy target on days 2 and 3 of mechanical ventilation. Secondary outcomes include protein intake, agreement between predicted and measured energy requirements, changes in resting energy expenditure over time, duration of mechanical ventilation, PICU length of stay, and incidence of nosocomial infections.
This pilot study aims to determine whether indirect calorimetry can improve the individualization and consistency of nutritional support in critically ill children.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
**Background and Rationale** Nutritional support is a key component of pediatric intensive care. Inadequate nutritional intake has been associated with prolonged mechanical ventilation, increased nosocomial infections, longer intensive care and hospital stays, and higher mortality.
Current international guidelines recommend early nutritional assessment and suggest indirect calorimetry as the preferred method for determining resting energy expenditure (REE). However, nutritional prescriptions in routine clinical practice frequently rely on predictive equations, particularly the Schofield equation, which may not accurately reflect the metabolic requirements of critically ill children.
A previous retrospective study conducted in our PICU, involving 141 mechanically ventilated children, demonstrated persistent variability in energy intake on days 2 and 3 despite the implementation of a standardized enteral nutrition protocol. These findings suggest that individualizing energy targets using directly measured REE could improve nutritional adequacy.
**Study Design and Population** CALI-PED is a single-center, prospective, non-randomized, interventional pilot study conducted at Montpellier University Hospital, France.
The prospective cohort will include 50 children younger than 18 years, weighing at least 10 kg, receiving invasive mechanical ventilation through a cuffed endotracheal tube, with an expected ventilation duration exceeding 48 hours.
The prospective cohort will be compared with a previously collected historical cohort of 141 mechanically ventilated children managed using conventional nutritional targets based on the Schofield predictive equation.
**Intervention** In the prospective cohort, REE will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit.
Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Before each measurement, respiratory settings must have remained unchanged for at least one hour. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period.
Daily enteral energy prescriptions will be adjusted according to the measured REE, expressed in kcal/day and kcal/kg/day.
**Primary Outcome** The primary outcome is the interindividual dispersion of the ratio between actual energy intake and the reference energy target on days 2 and 3 of mechanical ventilation.
The reference energy target will be defined as:
- Measured REE obtained by indirect calorimetry in the prospective cohort.
- Estimated energy requirements calculated using the Schofield equation in the historical cohort.
Interindividual dispersion will be assessed using the interquartile range and coefficient of variation.
**Secondary Outcomes**
Secondary outcomes include:
- Comparison of protein intake (g/kg/day) between cohorts on days 2 and 3.
- Comparison of Schofield-predicted energy requirements with indirect calorimetry-measured REE in the prospective cohort.
- Description of daily changes in measured REE during invasive mechanical ventilation, up to day 7.
- Exploratory comparison of mechanical ventilation duration, PICU length of stay, and incidence of nosocomial infections between cohorts.
Nosocomial infections will be defined as infections occurring at least 48 hours after admission, according to Centers for Disease Control and Prevention criteria.
**Statistical Analysis** The distributions of energy intake adequacy ratios will be compared between the prospective and historical cohorts using appropriate statistical methods. Normality will be assessed using the Shapiro-Wilk test, and continuous variables will be compared using parametric or non-parametric tests as appropriate.
Additional analyses may account for differences between the prospective and historical cohorts, including propensity score methods.
Clinical outcomes will be considered exploratory, as the study is not powered to demonstrate differences in clinical endpoints.
**Study Duration and Ethical Considerations** The recruitment period is expected to last 30 months. Participants will be followed until PICU discharge or day 28 after inclusion, whichever occurs first.
The study was approved by the Comité de Protection des Personnes Île-de-France VII on August 5, 2026 (reference 26.02032.000560). Written informed consent will be obtained from at least one parent or legal guardian, and assent will be obtained from the child whenever feasible.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Arthur Gavotto, MD, PhD
- Phone Number: +33 4 67 33 66 09
- Email: a-gavotto@chu-montpellier.fr
Study Locations
-
-
Occitanie
-
Montpellier, Occitanie, France, 34295
- Montpellier University Hospital - Arnaud de Villeneuve Hospital
-
Contact:
- Arthur Gavotto, MD, PhD
- Phone Number: +33 4 67 33 66 09
- Email: a-gavotto@chu-montpellier.fr
-
Principal Investigator:
- Arthur Gavotto, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children younger than 18 years of age.
- Body weight ≥10 kg.
- Invasive mechanical ventilation.
- Expected duration of invasive mechanical ventilation >48 hours.
- Child's assent to participate, whenever feasible.
- Written informed consent obtained from at least one parent or legal guardian.
Exclusion Criteria:
- Limitation or withdrawal of life-sustaining treatment planned at the time of admission to the pediatric intensive care unit.
- Brain death.
- Requirement for a specific dietary regimen due to an underlying condition, including diabetic ketoacidosis or an inherited metabolic disorder.
- Gastrointestinal disorders interfering with enteral nutrition, including short bowel syndrome or malabsorption.
- Participation in another research study with an ongoing exclusion period.
- Concurrent participation in another interventional clinical trial that could interfere with the present study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Indirect Calorimetry-Guided Nutrition
Fifty mechanically ventilated children will receive individualized enteral nutritional support guided by daily indirect calorimetry measurements. Resting energy expenditure will be measured from day 2 until extubation, for a maximum of seven days, and enteral caloric prescriptions will be adjusted accordingly. |
Resting energy expenditure (REE) will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit. Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period. Daily enteral caloric prescriptions will be adjusted according to the measured REE. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interindividual Variability in Energy Intake Adequacy on Days 2 and 3 of Mechanical Ventilation
Time Frame: Days 2 and 3 of invasive mechanical ventilation
|
Interindividual variability in the ratio of actual energy intake (kcal/kg/day) to the reference energy target will be compared between the prospective and historical cohorts on days 2 and 3 of mechanical ventilation. The reference energy target is defined as resting energy expenditure measured by indirect calorimetry in the prospective cohort and energy requirements estimated using the Schofield equation in the historical cohort. Interindividual variability will be primarily quantified using the interquartile range (IQR) of the energy intake adequacy ratio. The coefficient of variation (CV) will be calculated as a complementary measure of dispersion. |
Days 2 and 3 of invasive mechanical ventilation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily Protein Intake on Days 2 of Mechanical Ventilation
Time Frame: Days 2 of invasive mechanical ventilation
|
Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 2 of invasive mechanical ventilation. |
Days 2 of invasive mechanical ventilation
|
|
Daily Protein Intake on Days 3 of Mechanical Ventilation
Time Frame: Days 3 of invasive mechanical ventilation
|
Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 3 of invasive mechanical ventilation. |
Days 3 of invasive mechanical ventilation
|
|
Difference Between Predicted and Measured Resting Energy Expenditure
Time Frame: Days 2 to 7 of invasive mechanical ventilation
|
Difference between energy requirements estimated using the Schofield predictive equation and resting energy expenditure measured by indirect calorimetry in the prospective cohort, expressed in kcal/day. |
Days 2 to 7 of invasive mechanical ventilation
|
|
Daily Changes in Measured Resting Energy Expenditure
Time Frame: Days 2 to 7 of invasive mechanical ventilation
|
Daily resting energy expenditure measured by indirect calorimetry, expressed in kcal/day, will be described from day 2 until extubation, for a maximum of seven days of invasive mechanical ventilation, in the prospective cohort. |
Days 2 to 7 of invasive mechanical ventilation
|
|
Duration of Invasive Mechanical Ventilation
Time Frame: From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
|
Duration of invasive mechanical ventilation, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome. |
From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
|
|
Pediatric Intensive Care Unit Length of Stay
Time Frame: From PICU admission until PICU discharge, assessed up to day 28 after enrollment
|
Length of stay in the pediatric intensive care unit, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome. |
From PICU admission until PICU discharge, assessed up to day 28 after enrollment
|
|
Incidence of Nosocomial Infections
Time Frame: From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first
|
Proportion of patients developing at least one nosocomial infection, defined as an infection occurring at least 48 hours after PICU admission according to Centers for Disease Control and Prevention criteria. This exploratory clinical outcome will be compared between the prospective and historical cohorts. |
From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Arthur Gavotto, University Hospital, Montpellier
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL23_0109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data will not be made publicly available due to the sensitive nature of clinical information collected from critically ill pediatric patients and applicable data protection requirements. Study results will be disseminated through scientific publications and presentations in aggregated form.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.